JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook. Galapagos NV plans to split into two entities ...

Initiating coverage on PYPY, an ETF that combines exposure to PayPal Holdings Inc. stock with options, to create a dividend ...

Third Avenue Value Fund returned -9.59% in Q4 2024, as compared to the MSCI World Index 1, which returned -0.07%, and the ...

US President Donald Trump on Thursday accused the leaders of Bank of America and JPMorgan Chase of denying banking services to conservatives. Speaking via video link at the World Economic Forum in ...

Ordinarily, most investment trusts paying a dividend will seek to cover the cost from their underlying revenue, but one of ...

NEW YORK, Jan. 27, 2025 /PRNewswire/ -- J.P. Morgan Asset Management today released its seventh annual Global Alternatives Outlook, providing a 12-to-18 month outlook across key alternative asset ...

In a report released on January 21, John Ivankoe from J.P. Morgan maintained a Hold rating on Chipotle (CMG – Research Report), with a price ...

Larry Fink, the CEO of BlackRock, manages the world’s largest asset management firm, which handles a massive USD 7.4 trillion ...

Jamie Dimon praised Elon Musk as "our Einstein," resolving past legal disputes, while discussing JPMorgan's acquisition ...

Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ...

This past week, Elon Musk resurfaced a September 2016 interview in which Morgan Freeman told CNBC that he owned Tesla stock — a highly lucrative score for the actor should he have held on to it.